NCT01427816已完成2 期
A Randomized, Double Blind, Placebo Controlled, Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 180
- 试验地点
- 1
- 主要终点
- Corneal staining score
研究概览
简要总结
To evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndrome.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Corneal and conjunctival damage
- •Insufficiency of lacrimal secretion
- •Ocular symptom
排除标准
- •Severe ophthalmic disorder
- •Punctual plugs or surgery for occlusion of the lacrimal puncta
研究组 & 干预措施
KCT-0809 ophthalmic solution, low dose
Experimental
干预措施: KCT-0809 (Drug)
KCT-0809 ophthalmic solution, high dose
Experimental
干预措施: KCT-0809 (Drug)
Placebo
Placebo Comparator
干预措施: Placebo (Drug)
结局指标
主要结局
Corneal staining score
时间窗: 6 weeks
次要结局
- Conjunctival staining score(6 weeks)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Phase 2 Study of KLS-0611 in Patients With Dry Eye SyndromesDry Eye SyndromesNCT00721656Kissei Pharmaceutical Co., Ltd.80
已完成
3 期
A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeDry Eye With Sjögren's SyndromeNCT02503189Kissei Pharmaceutical Co., Ltd.
已完成
2 期
Safety and Efficacy of TOP1630 for Dry Eye SyndromeDry Eye SyndromeNCT03088605ORA, Inc.69
终止
3 期
An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeDry Eye With Sjögren's SyndromeNCT02503176Kissei Pharmaceutical Co., Ltd.
已完成
2 期
[KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye SyndromeDry Eye SyndromesNCT05017844Kukje Pharma222